Petros Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Petros Pharmaceuticals, Inc. (PTPI) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.36% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-04-15
- Petros Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was -0.36%.
- Petros Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.74%, a 182.22% decline from fiscal 2023.
- Petros Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 0.90%, a 36.62% decline from fiscal 2022.
- Petros Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 1.42%, a 80.89% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.36% 10-K · filed 2026-04-15 | |
| 2024-12-31 | -0.74% 10-K · filed 2026-04-15 | |
| 2023-12-31 | 0.90% 10-K · filed 2025-03-31 | |
| 2022-12-31 | 1.42% 10-K · filed 2024-04-01 | -0.08% 10-K · filed 2023-03-31 |
| 2021-12-31 | 7.43% 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |